[Antimalarial prophylaxis in travelers to malaria risk areas].

Epidemiol Mikrobiol Imunol

Ústav Preventicniho Lékarství LF UP Olomouc.

Published: April 2013

Malaria is one of the most common diseases imported to the Czech Republic with an upward trend in incidence. Travelers are leaving for abroad without antimalarial prophylaxis or refuse preventive antimalarial drugs. Failure to comply with antimalarial prophylaxis in high-risk areas can lead to malaria infection which may manifest itself even after returning home. As the disease is often mistaken for influenza, any traveler to malaria risk areas who presents with fever needs to be tested for malaria. Individual preventive measures consist in the correct use of repellents, insecticides, and bed nets LLITNs, wearing light colored clothing, and regular use of antimalarial prophylaxis.

Download full-text PDF

Source

Publication Analysis

Top Keywords

antimalarial prophylaxis
12
malaria risk
8
malaria
5
[antimalarial prophylaxis
4
prophylaxis travelers
4
travelers malaria
4
risk areas]
4
areas] malaria
4
malaria common
4
common diseases
4

Similar Publications

Epidemiological characteristics of imported malaria related to international travel in the Republic of Korea from 2009 to 2018.

Sci Rep

January 2025

Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Yonsei University Health System, 50-1, Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.

Malaria, transmitted by mosquitoes infected with Plasmodium parasites, remains a significant health issue with global travel increasing the risk of imported malaria. This study investigates imported malaria cases in the Republic of Korea from 2009 to 2018 using data from the Korea National Infectious Disease Surveillance System. During this period, 601 imported cases were reported, with 82.

View Article and Find Full Text PDF

Protective antibodies target cryptic epitope unmasked by cleavage of malaria sporozoite protein.

Science

January 2025

Antibody Biology Unit, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.

The most advanced monoclonal antibodies (mAbs) and vaccines against malaria target the central repeat region or closely related sequences within the circumsporozoite protein (PfCSP). Here, using an antigen-agnostic strategy to investigate human antibody responses to whole sporozoites, we identified a class of mAbs that target a cryptic PfCSP epitope that is only exposed after cleavage and subsequent pyroglutamylation (pGlu) of the newly formed N terminus. This pGlu-CSP epitope is not targeted by current anti-PfCSP mAbs and is not included in the licensed malaria vaccines.

View Article and Find Full Text PDF

Background: There are reports of a high prevalence of maternal peripheral and placental malarial parasitaemia (MP) in southeastern Nigeria following the two-dose regimen of sulphadoxine-pyrimethamine (SP) for intermittent preventive treatment (IPT) of malaria in pregnancy.

Objective: To compare the effectiveness of monthly versus two-dose regimens of SP for IPT of malaria in pregnancy in Enugu, south-eastern Nigeria.

Methods: A randomized controlled trial involving antenatal clinic attendees at the University of Nigeria Teaching Hospital (UNTH), Ituku-Ozalla, Enugu, Nigeria.

View Article and Find Full Text PDF

Background: Among the several strategies recommended for the fight against malaria, seasonal malaria chemoprevention (SMC) with sulfadoxine-pyrimethamine and amodiaquine combination (SPAQ) targets children 3 months to 5 years in Sahel regions of Africa to reduce mortality and mortality. Since SMC with SPAQ is administered to symptoms-free children for prevention of malaria, it is anticipated that a proportion of asymptomatic parasitaemic children will also be treated and may result in a drop in both the overall population prevalence of asymptomatic malaria infections, subsequent risk of symptomatic malaria infections and transmission. Age-specific carriage of asymptomatic Plasmodium spp.

View Article and Find Full Text PDF

Access and coverage of malaria services in Haiti in the context of elimination: a scoping review of the literature.

BMC Health Serv Res

December 2024

Equipe de Recherche sur l'Ecologie des Maladies Infectieuses et Tropicales, Université Quisqueya, Port-au-Prince, Haïti.

Introduction: Haiti is on the verge of possibly eliminating malaria, an endemic parasitic infection primarily caused by Plasmodium falciparum on the island of Hispaniola. Owing to its associated morbidity and mortality, malaria is a leading public health priority in Haiti. This scoping review aims to identify the scope of research on access and coverage of malaria surveillance, diagnosis, and treatment in Haiti in the elimination setting.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!